Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vorinostat and Doxil in Relapsed or Refractory Lymphomas
NCT00785798Phase 2Terminated
- Sponsor
- Yale University
- Start
- Jan 2009
- Primary completion
- Sep 2011
- Countries
- 1
01
Overview
Phase 2, open-label trial of vorinostat in lymphoma, sponsored by Yale University. Started Jan 2009; status: terminated.
02
Drugs
vorinostat
03
Conditions
lymphoma
Beyond the preview
Go deeper on NCT00785798.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00785798.